Obesity Drugs Covered By One-Third Of Large Employers In Survey
This article was originally published in The Pink Sheet Daily
Executive Summary
The National Business Group on Health survey illustrates the continuing reimbursement challenges faced by the recently introduced obesity drugs Qsymia and Belviq.